Open Access Highly Accessed Pre-publication history

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

Sabrina Thalita Reis*, José Pontes-Junior, Alberto Azoubel Antunes, Marcos Francisco Dall’Oglio, Nelson Dip, Carlo Camargo Passerotti, Guilherme Ayres Rossini, Denis Reis Morais, Adriano Joao Nesrallah, Camila Piantino, Miguel Srougi and Katia R Leite

BMC Urology 2012, 12:14  doi:10.1186/1471-2490-12-14

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 30 Jan 2012
Reviewer's Report Satoshi Anai 23 Feb 2012
Reviewer's Report Evan Gomes 06 Mar 2012
Resubmission - Version 2 Manuscript Author's comment 14 Mar 2012
Reviewer's Report Evan Gomes 29 Mar 2012
Resubmission - Version 3 Manuscript Author's comment 02 May 2012
Editorial acceptance 04 May 2012
Published 29 May 2012